Sumesh Parat1, Maroun Jean Mhanna2. 1. Department of Pediatrics, Division of Neonatology, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, OH, USA. 2. Department of Pediatrics, Division of Neonatology, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, OH, USA. mmhanna@metrohealth.org.
Abstract
BACKGROUND: To investigate strategies used for the management of respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) in extremely low birth weight (ELBW) infants. METHODS: A survey of neonatal specialists working in US academic institutions with fellowship training programs. RESULTS: Eighty percent (72/89) of the identified academic institutions had at least one physician who responded to the survey. Among respondents, 85% (171/201) agreed or strongly agreed to use continuous positive airway pressure (CPAP) initially for the management of RDS, and the majority agreed or strongly agreed to use a fraction of inspired oxygen (FiO2) ≥0.4 and a mean airway pressure (MAP) ≥10 cm H2O as a criteria for surfactant therapy; and 73% (146/200) sometimes or always used caffeine to prevent BPD. Only 25% (50/202) sometimes or almost always used steroids to prevent or treat BPD. Identified indications to use steroids were 3 or more extubation failures or inability to extubate beyond 8 weeks of age. CONCLUSIONS: Variability in treatment strategies of ELBW is common among neonatal specialists. However, the majority of the respondents agreed or strongly agreed to use early CPAP for the management of RDS, consider a FiO2 ≥0.4 and a MAP ≥10 cm H2O as criteria for surfactant therapy, and sometimes or almost always used caffeine to prevent BPD. Steroids continue to have a role in the management of BPD in infants who are difficult to extubate.
BACKGROUND: To investigate strategies used for the management of respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) in extremely low birth weight (ELBW) infants. METHODS: A survey of neonatal specialists working in US academic institutions with fellowship training programs. RESULTS: Eighty percent (72/89) of the identified academic institutions had at least one physician who responded to the survey. Among respondents, 85% (171/201) agreed or strongly agreed to use continuous positive airway pressure (CPAP) initially for the management of RDS, and the majority agreed or strongly agreed to use a fraction of inspired oxygen (FiO2) ≥0.4 and a mean airway pressure (MAP) ≥10 cm H2O as a criteria for surfactant therapy; and 73% (146/200) sometimes or always used caffeine to prevent BPD. Only 25% (50/202) sometimes or almost always used steroids to prevent or treat BPD. Identified indications to use steroids were 3 or more extubation failures or inability to extubate beyond 8 weeks of age. CONCLUSIONS: Variability in treatment strategies of ELBW is common among neonatal specialists. However, the majority of the respondents agreed or strongly agreed to use early CPAP for the management of RDS, consider a FiO2 ≥0.4 and a MAP ≥10 cm H2O as criteria for surfactant therapy, and sometimes or almost always used caffeine to prevent BPD. Steroids continue to have a role in the management of BPD in infants who are difficult to extubate.
Authors: Michael S Dunn; Joseph Kaempf; Alan de Klerk; Rose de Klerk; Maureen Reilly; Diantha Howard; Karla Ferrelli; Jeanette O'Conor; Roger F Soll Journal: Pediatrics Date: 2011-10-24 Impact factor: 7.124
Authors: Lucia J Smith; Karen O McKay; Peter P van Asperen; Hiran Selvadurai; Dominic A Fitzgerald Journal: Paediatr Respir Rev Date: 2010-01-25 Impact factor: 2.726
Authors: Ann R Stark; Waldemar A Carlo; Betty R Vohr; Lu Ann Papile; Shampa Saha; Charles R Bauer; William Oh; Seetha Shankaran; Jon E Tyson; Linda L Wright; W Kenneth Poole; Abhik Das; Barbara J Stoll; Avroy A Fanaroff; Sheldon B Korones; Richard A Ehrenkranz; David K Stevenson; Myriam Peralta-Carcelen; Deanne E Wilson-Costello; Henrietta S Bada; Roy J Heyne; Yvette R Johnson; Kimberly Gronsman Lee; Jean J Steichen Journal: J Pediatr Date: 2013-08-27 Impact factor: 4.406
Authors: Kristi L Watterberg; Michele L Shaffer; Mary J Mishefske; Corinne L Leach; Mark C Mammel; Robert J Couser; Soraya Abbasi; Cynthia H Cole; Susan W Aucott; Elizabeth H Thilo; Henry J Rozycki; Conra Backstrom Lacy Journal: Pediatrics Date: 2007-07 Impact factor: 7.124
Authors: Neil N Finer; Waldemar A Carlo; Michele C Walsh; Wade Rich; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Abhik Das; W Kenneth Poole; Edward F Donovan; Nancy S Newman; Namasivayam Ambalavanan; Ivan D Frantz; Susie Buchter; Pablo J Sánchez; Kathleen A Kennedy; Nirupama Laroia; Brenda B Poindexter; C Michael Cotten; Krisa P Van Meurs; Shahnaz Duara; Vivek Narendran; Beena G Sood; T Michael O'Shea; Edward F Bell; Vineet Bhandari; Kristi L Watterberg; Rosemary D Higgins Journal: N Engl J Med Date: 2010-05-16 Impact factor: 91.245
Authors: Ewa Gulczyńska; Tomasz Szczapa; Roman Hożejowski; Maria Katarzyna Borszewska-Kornacka; Magdalena Rutkowska Journal: Neonatology Date: 2019-05-21 Impact factor: 4.035
Authors: Wes Onland; Filip Cools; Andre Kroon; Karin Rademaker; Maruschka P Merkus; Peter H Dijk; Henrica L van Straaten; Arjan B Te Pas; Thilo Mohns; Els Bruneel; Arno F van Heijst; Boris W Kramer; Anne Debeer; Inge Zonnenberg; Yoann Marechal; Henry Blom; Katleen Plaskie; Martin Offringa; Anton H van Kaam Journal: JAMA Date: 2019-01-29 Impact factor: 56.272